Steven Sherman - Mar 21, 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
CEO & Chairman, Director
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Stock symbol
EKSO
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/22/2022, 04:55 PM
Previous filing
Mar 17, 2022
Next filing
Mar 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Options Exercise $0 +15.6K +2.56% $0.00 626K Mar 21, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EKSO Restricted Stock Units Options Exercise $0 -15.6K -9.09% $0.00 156K Mar 21, 2022 Common Stock 15.6K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
F2 The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested and settled as of January 21, 2023. The second installment of RSUs vested and were delivered to the Reporting Person on March 21, 2022.